Sean Mcbride Email & Phone Number

• Healthcare consultancy focused on go to market strategy, tactical optimization, market access, reimbursement & licensing.
• For rare disease company, analyze & provide guidance to optimize PLA's & streamline costs utilizing RWE & PSP data.
• Researched & developed commercial market & investor strategy for startup medical device company.
• Market assessment for US based company evaluating market entry, reimbursement & risks
• Life Sciences Ontario (LSO) Advisor, Government Relations & Policy Committee

Toronto, Ontario, CA

Organization supporting commercial success for Ontario's life sciences sector through policy change and advocacy.

Oakville, ON, CA

Mississauga, Ontario, CA

Provide leadership, commercial innovation/ strategy, and executional excellence; for biotech/pharma companies focused in Oncology, Neurology, Inflammation, and Rare Disease. Member Senior Leadership Team. Lead cross functional team of directors creating leading edge patient reimbursement and assistance programs. Oversight includes:- infusion nursing.

• Private/Venture capital backed startup company with $20M market cap focused only on US & EU markets.
• Oversaw BD & new product commercial market access, reimbursement & strategic positioning. Led, coached & developed team, established regional office and corporate processes including implementation of CRM system.
• Secured global license for vaccine supporting >50% of company value & an $80M+ FDA incentive. Led market and competitive evaluation, product diligence including HEOR research and full access team assessment, financial.
• Leveraged public and private market access models to develop unique go to market distribution strategy for rare disease product with accelerated regulatory status.
• Forged relations with F500 global partners (Merck, J&J, Pfizer, Roche), government, B2B and supply chain; providing strategic insight, new product opportunities & reduction in supply expenses.
• Negotiated & led resource and supply contracts, active pharmaceutical ingredient (API) and contract manufacturing agreements (CMO).

Brentford, Middlesex, GB

• Top 10, Global F500 pharmaceutical company with annual revenues of $35B USD, competing in public and private vaccines, & hospital based specialty products including oncology, hematology, respiratory, antivirals and CNS.
• Directed business unit with P&L responsibility, led financial and performance targets, generating $176M revenue representing 25% of GSK’s national business.
• Revised structure, staffed & coached a high performing team of (4) marketing, business development & (15) cross functional team. Matrix leadership for Medical, Regulatory, Finance, Manufacturing, QA, Legal.
• Led commercial strategy, analysis & planning including insight driven channel marketing (MCM) & GSK first pilots in digital/DTP campaigns, patient direct reimbursement & private PLA’s which directly added to performance.
• Led alignment of 3 yr franchise strategic plans to global vision, managed portfolio budget, optimized supply chain resulting in reduced COGs, business growth (+9%) & adherence metric improvements on priority brands.
• Represented Canada on global portfolio team responsible to streamline, restructure & revitalize portfolio profitability.

Brentford, Middlesex, GB

• Managed cross functional trade, tender & pricing strategy for ViiV, GSK and Stiefel portfolio, with stakeholders including government, Group Purchasing Organizations, Tumor Site Group leads, HTA groups, and private.
• Led national execution with provincial government affairs & private payer teams to integrate insights into strategy & ensure market access targets were met.
• Monitored & optimized pricing metrics including annual variance, net price performance, analysis of rebates & chargeback’s for contracts, and PMPRB reporting. Reduced rebates year over year.

Brentford, Middlesex, GB

• Facilitated cross functional strategic launch/business plans for specialty care & hematology/oncology brands, public/private & travel vaccines. Distilled & analyzed complex market, payer, KOL & global team insights.
• Developed a best in class launch readiness integrating global team, KOL, medical & patient advisory input into the business planning for innovative oncology product.
• Leveraged relations forged with Tumor Site Group Leads, reimbursement bodies and patient associations to shape market access, value strategy and budget impact assessment - directly supported formulary listing in two.
• Led analysis of market research data to inform & adjust strategy to maximize oncology / hematology portfolio to plan

• Consulting focused on product & distribution strategy, product assessments, reimbursement, HEOR & market access for launch. Supported pharmaceutical, medical device, diagnostic and Healthcare IT customers.
• Led project & client development on strategy & tactical plans for leading Canadian & US healthcare companies including UCB, Nycomed/Altana, Alpha Labs.

New York, NY, US

• AOR healthcare agency for J&J Pharma, medical device and diagnostic delivering strategy & DTC/DTP (Radio, TV, digital)
• Led market research, insight, strategy & message development for first drug eluting stent
• Centacor – enhancing PSP (Remicade)
• $40M DTC campaign development for neurosurgical shunt
• $30M Pilot DTC campaign development for hip & knee replacement
• DTC pilot development for point of care diagnostics

Switzerland 🇨🇭, CH

• Global Fortune 500, #2 globally, with annual revenues of $58B USD & hospital products in Cardiology, Oncology, HIV, transplant, CF, Growth Hormone & antivirals
• Staffed, coached & led hospital marketing & analytics team for an $85M business unit, P&L responsibility, led 4 cross functional life-cycle teams & managed alliance with Genentech & Roche Diagnostics to outperform.
• Led marketing and sales strategy, promotional development, market access and reimbursement programs to drive performance - Gained 98% market share despite a price >10X greater than competitor.
• Coached & directed marketing & sales teams to successful launch of new biologics (TNK, tPA Stroke, Cathflo), growth hormone (Nutropin), CF therapy (Pulmozyme - reimbursement), Rituxan & antivirals – Achieved.

Switzerland 🇨🇭, CH

• Staffed & led business unit including sales (7) & medical support (2). Budgets, business plans, commercial forecast, coaching & performance development - achieving top division & President's Award three out of 4 years.

Switzerland 🇨🇭, CH

• Brand marketing lead for hospital/specialty brand supporting sales force of 24 reps. Exceeded targets all 4 yrs.
• Development of adherence strategy drove patient utilization & delayed brand erosion by 1yr post LOE adding $21M in revenue.
• Supported brands in pain management, women's health and obesity.

Bba, Major: Marketing, Finance Minor: Economics

Csc, Securities, Finance

Master Of Business Administration - Mba, Strategy/ Digital Marketing